BNP Paribas Financial Markets
ALXO icon

BNP Paribas Financial Markets’s ALX Oncology ALXO Stock Holding History

BNP Paribas Financial Markets’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$934 Sell
466
-14
-3% -$27 ﹤0.01% 5482
2025
Q4 		$542 Hold
480
– – ﹤0.01% 5472
2025
Q3 		$878 Sell
480
-1,198
-71% -$1.04K ﹤0.01% 5249
2025
Q2 		$697 Sell
1,678
-5,912
-78% -$2.98K ﹤0.01% 5189
2025
Q1 		$4.73K Sell
7,590
-3,827
-34% -$4.59K ﹤0.01% 4862
2024
Q4 		$19.1K Buy
+11,417
New +$17.6K ﹤0.01% 4735
2022
Q4 		– Sell
-17,380
Closed -$166K – 4058
2022
Q3 		$166K Buy
+17,380
New +$203K ﹤0.01% 3566

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

BNP Paribas Financial Markets's ALXO Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its ALX Oncology (ALXO) stake by 2.9% in Q1 2026, selling an estimated $27 and leaving 466 shares worth $934. The position accounts for ﹤0.01% of the portfolio, ranked #5482.

BNP Paribas Financial Markets first reported a position in ALXO in Q3 2022 and has held it in 7 quarters since. The position peaked at $166K in Q3 2022. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • BNP Paribas Financial Markets held 466 shares of ALX Oncology worth $934 as of Q1 2026.
  • BNP Paribas Financial Markets sold 14 ALX Oncology shares in Q1 2026, an estimated $27.
  • ALX Oncology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5482 holding.
  • BNP Paribas Financial Markets first reported a position in ALX Oncology in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's ALX Oncology position peaked at $166K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.